FR2891830B1 - Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale - Google Patents

Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale

Info

Publication number
FR2891830B1
FR2891830B1 FR0510289A FR0510289A FR2891830B1 FR 2891830 B1 FR2891830 B1 FR 2891830B1 FR 0510289 A FR0510289 A FR 0510289A FR 0510289 A FR0510289 A FR 0510289A FR 2891830 B1 FR2891830 B1 FR 2891830B1
Authority
FR
France
Prior art keywords
medical imaging
metal complexes
aminoalcohol compounds
short
short aminoalcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0510289A
Other languages
English (en)
Other versions
FR2891830A1 (fr
Inventor
Marc Port
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guerbet SA
Original Assignee
Guerbet SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0510289A priority Critical patent/FR2891830B1/fr
Application filed by Guerbet SA filed Critical Guerbet SA
Priority to PT06807100T priority patent/PT1931673E/pt
Priority to PCT/EP2006/067214 priority patent/WO2007042506A1/fr
Priority to CN201310087412.9A priority patent/CN103224495B/zh
Priority to EP06807097.8A priority patent/EP1940841B9/fr
Priority to JP2008534029A priority patent/JP5317270B2/ja
Priority to CA2625196A priority patent/CA2625196C/fr
Priority to KR1020087010991A priority patent/KR20080080495A/ko
Priority to CA2625207A priority patent/CA2625207C/fr
Priority to ES06807100T priority patent/ES2390092T3/es
Priority to EP12153144.6A priority patent/EP2457914B1/fr
Priority to PCT/EP2006/067211 priority patent/WO2007042504A2/fr
Priority to US12/083,269 priority patent/US8926945B2/en
Priority to ES12153144.6T priority patent/ES2519369T3/es
Priority to PL06807100T priority patent/PL1931673T3/pl
Priority to EP06807100A priority patent/EP1931673B1/fr
Priority to DK06807100.0T priority patent/DK1931673T3/da
Priority to KR1020147009046A priority patent/KR101440761B1/ko
Priority to BRPI0617151A priority patent/BRPI0617151B8/pt
Priority to JP2008534028A priority patent/JP5368099B2/ja
Priority to US12/083,092 priority patent/US8114863B2/en
Priority to CN2006800416152A priority patent/CN101305006B/zh
Publication of FR2891830A1 publication Critical patent/FR2891830A1/fr
Publication of FR2891830B1 publication Critical patent/FR2891830B1/fr
Application granted granted Critical
Priority to US13/205,352 priority patent/US8986650B2/en
Priority to JP2013105720A priority patent/JP5731572B2/ja
Priority to JP2013107700A priority patent/JP5706926B2/ja
Priority to FR24C1006C priority patent/FR24C1006I1/fr
Priority to NL301259C priority patent/NL301259I2/nl
Priority to FIC20240003C priority patent/FIC20240003I1/fi
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/03—Monoamines
    • C07C211/05—Mono-, di- or tri-ethylamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
FR0510289A 2005-10-07 2005-10-07 Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale Active FR2891830B1 (fr)

Priority Applications (28)

Application Number Priority Date Filing Date Title
FR0510289A FR2891830B1 (fr) 2005-10-07 2005-10-07 Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
DK06807100.0T DK1931673T3 (da) 2005-10-07 2006-10-09 Forbindelser, der omfatter korte aminoalkoholkæder og metalkomplekser, til medicinsk billeddannelse
CN201310087412.9A CN103224495B (zh) 2005-10-07 2006-10-09 含有短氨基醇链的化合物和用于医学成像的金属络合物
EP06807097.8A EP1940841B9 (fr) 2005-10-07 2006-10-09 Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
JP2008534029A JP5317270B2 (ja) 2005-10-07 2006-10-09 医用画像のための短いアミノアルコール鎖および金属錯体を含む化合物
CA2625196A CA2625196C (fr) 2005-10-07 2006-10-09 Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
KR1020147009046A KR101440761B1 (ko) 2005-10-07 2006-10-09 의학 영상용 짧은 아미노알코올 사슬과 금속착물을 포함하는 화합물
CA2625207A CA2625207C (fr) 2005-10-07 2006-10-09 Composes comprenant des chaines aminoalcool courtes et des complexes metalliques en imagerie medicale
ES06807100T ES2390092T3 (es) 2005-10-07 2006-10-09 Compuestos que comprenden cadenas de aminoalcohol cortas y complejos metálicos para la obtención de imágenes médicas
EP12153144.6A EP2457914B1 (fr) 2005-10-07 2006-10-09 Composés comprenant des chaînes d'amino-alcool courtes et des complexes métalliques pour l'imagerie médicale
PCT/EP2006/067211 WO2007042504A2 (fr) 2005-10-07 2006-10-09 Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
PCT/EP2006/067214 WO2007042506A1 (fr) 2005-10-07 2006-10-09 Composés comprenant des chaînes aminoalcool courtes et des complexes métalliques en imagerie médicale
ES12153144.6T ES2519369T3 (es) 2005-10-07 2006-10-09 Compuestos que comprenden cadenas de aminoalcohol cortas y complejos metálicos para la obtención de imágenes médicas
PL06807100T PL1931673T3 (pl) 2005-10-07 2006-10-09 Związki zawierające krótkie łańcuchy aminoalkoholowe i kompleksy metali do obrazowania medycznego
PT06807100T PT1931673E (pt) 2005-10-07 2006-10-09 Compostos que compreendem cadeias de aminoálcoois e complexos metálicos para imagiologia médica
EP06807100A EP1931673B1 (fr) 2005-10-07 2006-10-09 Composés comprenant des chaînes aminoalcool courtes et des complexes métalliques en imagerie médicale
KR1020087010991A KR20080080495A (ko) 2005-10-07 2006-10-09 의학 영상용 짧은 아미노알코올 사슬과 금속착물을포함하는 화합물
BRPI0617151A BRPI0617151B8 (pt) 2005-10-07 2006-10-09 composto, multímero, composto vetorizado, complexo do referido composto, bem como composições farmacêutica, farmacêutica lipídica e de diagnóstico para imagiologia por ressonância magnética e processo para a preparação de um complexo metálico
JP2008534028A JP5368099B2 (ja) 2005-10-07 2006-10-09 ガリウムと錯体形成することが可能なシグナル部分にカップリングされた、生物学的標的の認識のための部分を含んでなる化合物
US12/083,092 US8114863B2 (en) 2005-10-07 2006-10-09 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
CN2006800416152A CN101305006B (zh) 2005-10-07 2006-10-09 含有短氨基醇链的化合物和用于医学成像的金属络合物
US12/083,269 US8926945B2 (en) 2005-10-07 2006-10-09 Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
US13/205,352 US8986650B2 (en) 2005-10-07 2011-08-08 Complex folate-NOTA-Ga68
JP2013105720A JP5731572B2 (ja) 2005-10-07 2013-05-20 医用画像のための短いアミノアルコール鎖および金属錯体を含む化合物
JP2013107700A JP5706926B2 (ja) 2005-10-07 2013-05-22 ガリウムと錯体形成することが可能なシグナル部分にカップリングされた、生物学的標的の認識のための部分を含んでなる化合物
FR24C1006C FR24C1006I1 (fr) 2005-10-07 2024-02-19 Composes comprenant des chaines aminoalcool courtes et des complexes metalliques en imagerie medicale
NL301259C NL301259I2 (nl) 2005-10-07 2024-02-21 Gadopiclenol
FIC20240003C FIC20240003I1 (fi) 2005-10-07 2024-02-26 Gadopiklenoli

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0510289A FR2891830B1 (fr) 2005-10-07 2005-10-07 Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale

Publications (2)

Publication Number Publication Date
FR2891830A1 FR2891830A1 (fr) 2007-04-13
FR2891830B1 true FR2891830B1 (fr) 2011-06-24

Family

ID=36636179

Family Applications (2)

Application Number Title Priority Date Filing Date
FR0510289A Active FR2891830B1 (fr) 2005-10-07 2005-10-07 Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
FR24C1006C Active FR24C1006I1 (fr) 2005-10-07 2024-02-19 Composes comprenant des chaines aminoalcool courtes et des complexes metalliques en imagerie medicale

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR24C1006C Active FR24C1006I1 (fr) 2005-10-07 2024-02-19 Composes comprenant des chaines aminoalcool courtes et des complexes metalliques en imagerie medicale

Country Status (15)

Country Link
US (1) US8114863B2 (fr)
EP (2) EP2457914B1 (fr)
JP (2) JP5317270B2 (fr)
KR (2) KR20080080495A (fr)
CN (2) CN103224495B (fr)
BR (1) BRPI0617151B8 (fr)
CA (1) CA2625207C (fr)
DK (1) DK1931673T3 (fr)
ES (2) ES2390092T3 (fr)
FI (1) FIC20240003I1 (fr)
FR (2) FR2891830B1 (fr)
NL (1) NL301259I2 (fr)
PL (1) PL1931673T3 (fr)
PT (1) PT1931673E (fr)
WO (1) WO2007042506A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
FR2914303A1 (fr) * 2007-03-28 2008-10-03 Guerbet Sa Composes pour le diagnostic de l'apoptose.
US8378134B2 (en) 2009-09-30 2013-02-19 General Electric Company Hydroxylated contrast enhancement agents
US20110077396A1 (en) * 2009-09-30 2011-03-31 General Electric Company Intermediates for hydroxylated contrast enhancement agents
FR2968999B1 (fr) 2010-12-20 2013-01-04 Guerbet Sa Nanoemulsion de chelate pour irm
CA2839647C (fr) * 2011-08-17 2022-08-16 Merck & Cie Conjugues avec des folates d'entites de liaison de l'albumine
FR2980364B1 (fr) 2011-09-26 2018-08-31 Guerbet Nanoemulsions et leur utilisation comme agents de contraste
FR3001154B1 (fr) 2013-01-23 2015-06-26 Guerbet Sa Magneto-emulsion vectorisee
BR112015026473B1 (pt) * 2013-04-26 2020-12-01 Guerbet composições farmacêuticas líquidas e processo de preparação das mesmas e meio de contraste para imagiologia médica
CN103467504B (zh) * 2013-09-23 2015-06-24 武汉工程大学 18f-氟标记卟啉-异氮杂茚自由基配合物及合成方法
CN104485193B (zh) * 2014-12-29 2016-11-02 广西师范大学 一种以酰腙类希夫碱为配体构筑的磁性材料及其制备方法
EP3101012A1 (fr) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft Nouveaux composés de chélate de gadolinium pour une utilisation dans l'imagerie par résonance magnétique
FR3039767B1 (fr) 2015-08-04 2017-09-08 Guerbet Sa Composition destinee a vectoriser un agent anticancereux
SG11201804412SA (en) * 2015-12-10 2018-06-28 Bracco Imaging Spa Dimeric contrast agents
EP3223181B1 (fr) 2016-03-24 2019-12-18 Sofradim Production Système et procédé de génération d'un modèle et de simulation d'un effet sur un site de réparation chirurgicale
US11007283B2 (en) * 2016-04-13 2021-05-18 Bracco Imaging S.P.A. Contrast agents
GB201610738D0 (en) * 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
JP7034160B2 (ja) 2016-11-28 2022-03-11 バイエル・ファルマ・アクティエンゲゼルシャフト 磁気共鳴画像法に使用するための高緩和度ガドリニウムキレート化合物
DK3558394T3 (da) 2016-12-21 2020-08-24 Ge Healthcare As Tetraazabicyklo-macrocykel-baseret mangan-chelatforbindelser egnede som mri-kontraststoffer
FR3069245B1 (fr) * 2017-07-21 2019-07-26 Guerbet Ligands macrocycliques lipophiles, leurs complexes ainsi que leurs utilisations medicales
CN111712477B (zh) 2017-12-20 2024-02-02 通用电气公司 阴离子螯合物化合物
WO2020030618A1 (fr) 2018-08-06 2020-02-13 Bracco Imaging Spa Agents de contraste à base de pcta portant du gadolinium
US11944690B2 (en) 2018-11-23 2024-04-02 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof
US11370804B2 (en) 2019-01-17 2022-06-28 Guerbet Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process
FR3091873B1 (fr) 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
US11426470B2 (en) 2019-01-17 2022-08-30 Guerbet Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched PCTA and synthesis method
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
EP4143153B1 (fr) 2020-07-16 2023-09-20 Guerbet Procédé de synthèse de diesters d'acide 2-bromoglutarique
CN111875667B (zh) * 2020-07-16 2021-12-21 南方科技大学 有机金属螯合物及其制备方法与应用、探针
KR20230041007A (ko) 2020-07-17 2023-03-23 게르브 Pcta로부터 유도된 킬레이팅 리간드의 제조 방법
CN114105983B (zh) * 2021-11-09 2023-08-11 国科温州研究院(温州生物材料与工程研究所) 手性1,4,7,10-四氮杂-2,6-吡啶环蕃衍生物及其金属螯合物的制备和应用
WO2024049087A1 (fr) * 2022-09-01 2024-03-07 주식회사 테라노큐어 Nouveau composé et agent de contraste irm le comprenant

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135748A (en) 1960-05-27 1964-06-02 Little Inc A Heterocyclic substituted carbodhmides and method of preparation
DE4001655A1 (de) * 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5334371A (en) 1988-07-20 1994-08-02 Schering Aktiengesellschaft Marcocyclic polyaza bicyclo compounds containing 5 or 6 membered rings, and method for MRI
DE3825040A1 (de) * 1988-07-20 1990-01-25 Schering Ag 5- oder 6-ring- enthaltende makrocyclische polyaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5554748A (en) 1989-04-07 1996-09-10 Nycomed Salutar, Inc. Adducts of macrocyclic chelants
SG48889A1 (en) 1991-12-10 1998-05-18 Dow Chemical Co Bicycle-polyamacrocyclocarboxylic acid complexes conjugates preparation and use as contrast agents
DK0661279T3 (da) * 1993-12-30 2001-07-16 Guerbet Sa Polyaminiserede ligander, metalkomplekser, fremgangsmåde til deres fremstilling og diagnostiske og terapeutiske anvendelser
ES2257771T3 (es) 1996-10-28 2006-08-01 Amersham Health As Agentes de contraste.
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
US6071490A (en) 1998-05-07 2000-06-06 Immunomedics, Inc. Position emission tomography using gallium-68 chelates
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
FR2794744B1 (fr) * 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
AU768859B2 (en) 1999-07-29 2004-01-08 Dyax Corp. Binding moieties for fibrin
AU2001236485A1 (en) * 2000-01-21 2001-07-31 Mallinckrodt, Inc. Novel orthogonally protected amino acid chelators for biomedical applications
US6450956B1 (en) 2000-11-06 2002-09-17 Siemens Corporate Research, Inc. System and method for treatment and outcome measurement analysis
ITMI20011518A1 (it) * 2001-07-17 2003-01-17 Bracco Imaging Spa Leganti azotati multidentati capaci di complessare ioni metallici e loro uso in diagnostica e in terapia
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
FR2836916B1 (fr) * 2002-03-05 2004-06-11 Guerbet Sa Oligomeres de chelates de gadolinium, leur application comme produits de contraste en imagerie par resonance magnetique et leurs intermediaires de synthese
WO2005001415A2 (fr) 2003-05-23 2005-01-06 Epix Pharmaceuticals, Inc. Isomeres optiquement purs et enrichis de ligands chelateurs et agents de contraste
FR2856689A1 (fr) 2003-06-25 2004-12-31 Guerbet Sa Composes specifiques a forte relaxivite
CA2783275A1 (fr) 2003-07-24 2005-02-03 Bracco Imaging S.P.A. Compositions radiopharmaceutiques stables et methodes pour leur preparation
US20050136003A1 (en) 2003-10-31 2005-06-23 Casebier David S. Novel chemical agents comprising a cardiotonic moiety and an imaging moiety and methods of their use
GB0326546D0 (en) 2003-11-14 2003-12-17 Amersham Plc Inhibitor imaging agents
WO2005049095A2 (fr) 2003-11-24 2005-06-02 Amersham Health As Agent de contraste
EP1699466A4 (fr) 2003-12-23 2009-03-11 Bracco Spa Nouveaux composes utiles comme chelateurs de metaux
WO2006002873A2 (fr) 2004-07-02 2006-01-12 Bracco Imaging Spa Agents de contraste a relaxivite accrue
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale

Also Published As

Publication number Publication date
JP2013209400A (ja) 2013-10-10
KR20080080495A (ko) 2008-09-04
PT1931673E (pt) 2012-09-24
JP5731572B2 (ja) 2015-06-10
NL301259I2 (nl) 2024-03-25
EP2457914B1 (fr) 2014-08-06
US8114863B2 (en) 2012-02-14
EP1931673A1 (fr) 2008-06-18
CN103224495A (zh) 2013-07-31
EP1931673B1 (fr) 2012-08-29
CN101305006A (zh) 2008-11-12
US20090169479A1 (en) 2009-07-02
BRPI0617151B1 (pt) 2020-08-11
ES2519369T3 (es) 2014-11-06
CA2625207C (fr) 2014-05-13
BRPI0617151B8 (pt) 2021-07-27
JP5317270B2 (ja) 2013-10-16
PL1931673T3 (pl) 2012-11-30
BRPI0617151A2 (pt) 2011-07-12
CN101305006B (zh) 2013-04-24
JP2009513574A (ja) 2009-04-02
FR24C1006I1 (fr) 2024-04-19
CA2625207A1 (fr) 2007-04-19
WO2007042506A1 (fr) 2007-04-19
KR20140060565A (ko) 2014-05-20
FIC20240003I1 (fi) 2024-02-26
ES2390092T3 (es) 2012-11-06
KR101440761B1 (ko) 2014-09-17
CN103224495B (zh) 2015-07-15
EP2457914A1 (fr) 2012-05-30
FR2891830A1 (fr) 2007-04-13
DK1931673T3 (da) 2012-10-08

Similar Documents

Publication Publication Date Title
FR2891830B1 (fr) Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
EP1809601A4 (fr) Composes destines a la maladie d'alzheimer
HK1206104A1 (en) Confocal microscope for imaging of selected locations of the body of a patient
EP1940373B8 (fr) 1-fluoro-1-deoxy-scyllo-inositol destine au traitement de la maladie d'alzheimer
IL188165A0 (en) Method for the diagnosis of alzheimer's disease
GB0524865D0 (en) Imaging catheter
FR2857200B1 (fr) Processeur video pour l'endoscopie
EP2011513A4 (fr) Agents thérapeutiques employés dans le cadre de la maladie d'alzheimer et du cancer
EP1817050A4 (fr) Diagnostic et traitement de la maladie d'alzheimer
EP1638612A4 (fr) Agents d'imagerie a cible de cox-2
FR2862861B1 (fr) Positionnement d'objets pour l'acquisition d'images
EE200300216A (et) Radiofarmatseutilised ained Alzheimeri tõve diagnoosimiseks
FR2872963B1 (fr) Piece d'extremite femelle
EP1450863A4 (fr) Procedes d'imagerie vasculaire comprenant l'utilisation d'agents de contraste nanoparticulaires
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
PL2446869T3 (pl) Element zapięcia pieluchy
GB2415896B (en) An angler's seat box
FR2882248B1 (fr) Porcede et systeme pour aider au guidage d'un outil a usage medical
GB0414894D0 (en) Biomarkers of alzheimer's disease
IL172690A0 (en) Methods for the diagnosis and prognosis of alzheimer's disease
FR2837285B1 (fr) Pack d'imagerie ultrasonore
AU2003236714A8 (en) Diagnosis of alzheimer's disease based on the habeta42:habeta40 ratio
EP1832877A4 (fr) Methode de diagnostic de la maladie d'alzheimer
GB2409587B (en) 'Kwicap'
HU0600409D0 (en) Izatin and it's derivatives for use as a medicine

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19